Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models

BACKGROUND: Immuno-oncology therapies are now part of the standard of care for cancer in many indications. However, durable objective responses remain limited to a subset of patients. As such, there is a critical need to identify biomarkers that can predict or enrich for treatment response. So far,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitnikova, Suzanne Isabelle, Munnings-Tomes, Sophie, Galvani, Elena, Kentner, Stacy, Mulgrew, Kathy, Rands, Chris, España Agustí, Judit, Zhang, Tianhui, Ilieva, Kristina M, Rosignoli, Guglielmo, Ghadially, Hormas, Robinson, Matthew J, Slidel, Tim, Wilkinson, Robert W, Dovedi, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215240/
https://www.ncbi.nlm.nih.gov/pubmed/34145033
http://dx.doi.org/10.1136/jitc-2021-002894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215240/
https://www.ncbi.nlm.nih.gov/pubmed/34145033
http://dx.doi.org/10.1136/jitc-2021-002894

Ejemplares similares